Welcome to the second edition of the Synple Pulse. This month we'll be sharing
more details on some of our new applications, as well as further details on our
new Synple Unity parallel synthesiser. In addition, we've highlighted three new
publications as ourTop 3 Picks of the Month, which we hope are of interest to
you. Read on to find out more!
If you missed our previous editions you can find an archive here
http://www.synplechem.com/news/synple-pulse.
Dear <<First Name>>, Welcome to the second edition of the Synple Pulse. This month we'll be sharing more details on some of our new applications, as well as further details on our new Synple Unity parallel synthesiser. In addition, we've highlighted three new publications as our Top 3 Picks of the Month, which we hope are of interest to you. Read on to find out more! If you missed our previous editions you can find an archive here. |
|
Our new Synple Unity parallel synthesiser, controlled by a central terminal, allows the user to expand the number of module to reach the capacity they require. The system can be used for making small libraries of compounds biological testing or for screening a range of reaction conditions to identify the best synthetic route. Please get in touch for more information on Synple Unity: info@synplechem.com. continue reading... |
|
|
|
Synple's Top Pick of the Month - 1 |
|
|
New biological tools provide new techniques to probe fundamental biological processes. One such class of tools are PROTACs, which offer the potential to greatly expand the druggable proteome. continue reading... |
|
|
|
PROTACs - an Expanding Application |
|
|
Proteolysis targeting chimeras (PROTACs), consisting of two bioactive domains – one E3 ligase binder and one target protein binder – connected via a linker, can induce selective degradation of proteins and as such, offer a great deal of promise in the drug discovery field. Despite this, one of the major drawbacks is the lead time for PROTAC development, which can involve substantial synthetic and medicinal chemistry. We have developed a range of methods and cartridges, containing a range of partial PROTACs, which are capable of effecting PROTAC synthesis and purification in an automated manner. continue reading... |
|
|
|
Synple's Top Pick if the Month - 2 |
|
|
This J. Med. Chem article offers a great analysis of how aliphatic fluorination affects, and can be used to modulate, lipophilicity. continue reading... |
|
|
|
Fluorine can play an important role in drug design and development. Introduction of a fluorine substituent into a drug molecule can influence a wide range of properties, including pKa, potency, permeability, metabolic liability, and structural conformation. Given its potential effects, there has been a strong drive towards the development of new synthetic methodologies that enable the facile introduction of fluorine at a late stage in the synthesis. Synple are aiming to take things even further and provide automated methods and cartridges for late-stage fluorination. continue reading... |
|
|
|
Synple's Top Pick of the Month - 3 |
|
|
This year at the Automated Synthesis Forum, it was abundantly clear that synthetic organic chemistry is becoming increasingly automated, data rich and intelligent.This report highlights the progress both industry and academia are making in this field. continue reading... |
|
|
|
In our future newsletters, we will be selecting a few of our favourite articles of the month, that we feel could be of interest to you. If you find anything you would like to share with us or other Synple users, please send it to us articles@synplechem.com. We look forward to your input! |
|
|
Fully Automated, Capsule-based Synthesis | Synple Chem provides new automated synthesizers using revolutionary reagent capsules to make the synthesis of molecules faster and more efficient. Using this technology researchers in chemistry will be able to advance their programs in a fraction of the time. | |
|
© 2020 Synple Chem AG. All Rights Reserved. | |
|
|